company background image
EVH logo

Evolent Health Informe acción NYSE:EVH

Último precio

US$11.25

Capitalización de mercado

US$1.3b

7D

-9.1%

1Y

-62.2%

Actualizada

24 Nov, 2024

Datos

Finanzas de la empresa +

Evolent Health, Inc.

Informe acción NYSE:EVH

Capitalización de mercado: US$1.3b

Resumen de acción EVH

Evolent Health, Inc. a través de su filial Evolent Health LLC, ofrece servicios de gestión de cuidados especializados en los mercados de oncología, cardiología y musculoesquelético en Estados Unidos. Saber más

Análisis fundamental de EVH
Puntuación del snowflake
Valoración5/6
Crecimiento futuro4/6
Rendimiento pasado0/6
Salud financiera3/6
Dividendos0/6

Competidores de Evolent Health, Inc.

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Evolent Health
Precios históricos de las acciones
Precio actual de la acciónUS$11.25
Máximo en las últimas 52 semanasUS$35.00
Mínimo de 52 semanasUS$11.17
Beta1.59
1Cambio en 1 mes-53.16%
Variación en 3 meses-64.42%
Cambio de 1 año-62.18%
3Variación en 3 años-57.19%
Variación en 5 años56.03%
Variación desde la OPV-40.35%

Noticias y actualizaciones recientes

Evolent Health: A Shot At Revival After Market Bruising

Nov 12

Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper

Nov 09
Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper

We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Nov 07
We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Recent updates

Evolent Health: A Shot At Revival After Market Bruising

Nov 12

Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper

Nov 09
Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper

We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Nov 07
We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Sep 19
Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Evolent Health: Let The Bidding Begin

Aug 23

Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Jul 29
Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Jul 01
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)

May 22

These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

May 05
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Apr 08
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Mar 12
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Jan 17
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Dec 21
Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

Nov 30
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

A First Evaluation On Evolent Health

Oct 04

Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

Sep 29
Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

Sep 01
There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Aug 04
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Evolent Health: Business Economics Still Appealing, Reiterate Buy

Jul 19

Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Jun 14
Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

May 30
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

May 02
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Apr 17
Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M

Feb 22

Is Evolent Health (NYSE:EVH) A Risky Investment?

Feb 19
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return

Feb 15

Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Feb 01
Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Jan 14
Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Evolent spikes as Humana partnership expands

Jan 12

Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Dec 27
Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Evolent Health offered $23.5M class action securities settlement

Sep 19

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Sep 18
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Rentabilidad de los accionistas

EVHUS Healthcare ServicesMercado US
7D-9.1%2.1%2.2%
1Y-62.2%8.2%31.6%

Rentabilidad vs. Industria: Los resultados de EVH fueron inferiores a los de la industria US Healthcare Services, que obtuvo un rendimiento del 8.2% el año pasado.

Rentabilidad vs. Mercado: EVH obtuvo unos resultados inferiores a los del mercado US, que fueron del 31.6% el año pasado.

Volatilidad de los precios

Is EVH's price volatile compared to industry and market?
EVH volatility
EVH Average Weekly Movement14.7%
Healthcare Services Industry Average Movement9.1%
Market Average Movement6.3%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Precio estable de las acciones: El precio de las acciones de EVH ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de EVH(15%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de US.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
20114,700Seth Blackleywww.evolent.com

Evolent Health, Inc. a través de su filial Evolent Health LLC, ofrece servicios de gestión de atención especializada en los mercados de oncología, cardiología y musculoesquelético en Estados Unidos. La empresa proporciona plataformas para la administración de planes de salud e infraestructuras empresariales basadas en el valor. Ofrece servicios administrativos, como servicios de planes de salud, gestión de beneficios farmacéuticos, gestión de riesgos, análisis e informes, y liderazgo y gestión; e Identifi, un sistema tecnológico propio que agrega y analiza datos, gestiona flujos de trabajo asistenciales e involucra a los pacientes.

Resumen de fundamentos de Evolent Health, Inc.

¿Cómo se comparan los beneficios e ingresos de Evolent Health con su capitalización de mercado?
Estadísticas fundamentales de EVH
Capitalización bursátilUS$1.29b
Beneficios(TTM)-US$104.23m
Ingresos (TTM)US$2.46b

0.5x

Ratio precio-ventas (PS)

-12.4x

Ratio precio-beneficio (PE)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de EVH
IngresosUS$2.46b
Coste de los ingresosUS$2.07b
Beneficio brutoUS$393.27m
Otros gastosUS$497.50m
Beneficios-US$104.23m

Últimos beneficios comunicados

Sep 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)-0.91
Margen bruto15.96%
Margen de beneficio neto-4.23%
Ratio deuda/patrimonio48.9%

¿Cómo se ha desempeñado EVH a largo plazo?

Ver rendimiento histórico y comparativa